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Abstract
The present study evaluated low-level laser therapy (LLLT) effects on some physiological
pathways that may lead to muscle damage or regeneration capacity in dystrophin-deficient
muscle cells ofmdxmice, the experimental model of Duchenne muscular dystrophy (DMD).
Primary cultures ofmdx skeletal muscle cells were irradiated only one time with laser and
analyzed after 24 and 48 hours. The LLLT parameter used was 830 nm wavelengths at 5 J/
cm² fluence. The following groups were set up: Ctrl (untreated C57BL/10 primary muscle
cells),mdx (untreatedmdx primary muscle cells),mdx LA 24 (mdx primary muscle cells -
LLLT irradiated and analyzed after 24 h), andmdx LA 48 (mdx primary muscle cells - LLLT
irradiated and analyzed after 48 h). Themdx LA 24 andmdx LA 48 groups showed signifi-
cant increase in cell proliferation, higher diameter in muscle cells and decreased MyoD lev-
els compared to themdx group. Themdx LA 48 group showed significant increase in
Myosin Heavy Chain levels compared to the untreatedmdx andmdx LA 24 groups. The
mdx LA 24 andmdx LA 48 groups showed significant increase in [Ca
2+
]i. Themdx group
showed significant increase in H2O2 production and 4-HNE levels compared to the Ctrl
group and LLLT treatment reduced this increase. GSH levels and GPx, GR and SOD activi-
ties increased in themdx group. Laser treatment reduced the GSH levels and GR and SOD
activities in dystrophic muscle cells. Themdx group showed significant increase in the TNF-
α and NF-κB levels, which in turn was reduced by the LLLT treatment. Together, these re-
sults suggest that the laser treatment improved regenerative capacity and decreased in-
flammatory response and oxidative stress in dystrophic muscle cells, indicating that LLLT
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could be a helpful alternative therapy to be associated with other treatment
for dystrophinopathies.
Introduction
Duchenne muscular dystrophy (DMD) is a degenerative and progressive muscular disease
caused by the absence of the dystrophin protein, affecting about 1 in 3,500 male births and for
which there is no effective therapy [1]. Corticosteroids are currently the standard treatment
prescribed to DMD patients, but their benefits are modest and they have numerous side effects
[2].
Abnormal reactive oxygen species (ROS) level and exaggerated inflammatory process con-
tribute strongly to pathological mechanisms triggered by the absence of dystrophin in DMD
[3–7]. Elevated levels of nuclear factor kappa-B (NF-κB), a transcription factor that regulates
the expression of pro-inflammatory cytokines [3], and tumor necrosis factor alpha (TNF-α), a
key cytokine that stimulates the inflammatory response [4] are found in circulating blood and
in skeletal muscles in DMD patients andmdxmice, the experimental model of DM [5–7]. In
addition, dystrophic muscle fibers of DMD patients andmdxmice display high levels of oxida-
tive stress markers and lipid peroxidation by-products [6, 8–10].
Low-level laser therapy (LLLT) has been used in the treatment of inflammatory diseases,
mainly in musculoskeletal disorders such as tendinopathies [11] and muscle injuries [12]. This
therapy shows modulatory effects on NF-κB, TNF-α, IL-1β and COX-2 inflammatory markers
[13–15]; reduces the inflammatory process itself (e.g. edema and hemorrhagic formation) [16];
and modulates leucocyte activity [17]. LLLT has also demonstrated favorable effects in modu-
lating the oxidative stress by decreased ROS [18] and increased activity of antioxidant enzymes
such as superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) [19].
Considering that LLLT shows potential effects on oxidative stress and inflammatory re-
sponse and also exhibits an advantage over the pharmacological therapy by not having severe
side effects [12], we evaluated the effects of LLLT therapy on some physiological pathways that
may lead to muscle damage or regeneration capacity in the dystrophin-deficient muscle cells of
mdxmice. By using the in vitro cell culture of dystrophic fibers, we were able to better evaluate
ROS production and inflammatory cytokines by dystrophin-deficient fibers per se specifically,
without the interference of other cells normally present in the whole tissue, such as macro-
phages that contribute to H2O2 and TNF-α production.
Materials and Methods
Cell cultures
C57BL/10 mice (C57BL/10ScCr/PasUnib) andmdxmice (C57BL/10-Dmdmdx/PasUnib) were
housed in animal house of State University of Campinas (UNICAMP), with food and water
being available ad libitum. The animal experiments described here were conducted in accor-
dance with the guidelines of the Brazilian College for Animal Experimentation and the guide-
lines set forth by our institution. The protocol (#2974–1) was approved by the Committee on
the Ethics of Animal Experiments of UNICAMP, São Paulo, Brazil. Primary culture of skeletal
muscle cells (PCSMC) was performed following the method described by Rando and Blau [20].
Male and female frommdx and C57BL/10 mice were sacrificed at 28 days of age by decapita-
tion. The quadriceps femoris, tibialis anterior, extensor digitorum longus, gastrocnemius, sole-
us, and plantaris muscles were removed and used to prepare primary muscle culture. Muscles
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were triturated using a pair of scissors and enzymatically digested with collagenase and trypsin
solutions at 37°C. The satellite cells (5x104 cells/cm2) were plated in 1%Matrigel-coated dishes.
The primary muscle cells were cultured in a proliferation and growth medium containing
DMEM with glucose (5.5 mM), L-glutamine (2 mM), fetal bovine serum (10% v/v), horse
serum (10% v/v), and penicillin/streptomycin (1% v/v) for 2 days. Myogenesis (myotube differ-
entiation) was induced by the addition of a fusion medium (FM) that consisted of DMEM with
glucose (5.5 mM), Lglutamine (2 mM), and horse serum (10% v/v). The culture was main-
tained at 37°C and 5% CO2 and the differentiated muscle cells with contractile properties were
observed at 6–8 days of culture in the FM. Skeletal muscle cell cultures at 6–8 days were used in
all experiments and all measurements were obtained from triplicate cultures. The following
groups were studied:(1) Ctrl (primary muscle cells from C57BL/10 mice that did not receive
any treatment), (2)mdx untreated (primary muscle cells frommdxmice that did not receive
any treatment), (3)mdx LA 24 (primary muscle cells frommdxmice that received irradiation
one time alone with LLLT and analyzed after 24 h), and (4)mdx LA 48 (primary muscle cells
frommdxmice that received irradiation one time alone with LLLT and analyzed after 48 h).
Low-level laser therapy
The experiments were conducted with the Aluminum Gallium Arsenide (AIGaAs) diode,
830 nm wavelength at 5 J/cm² fluence, continuous emission during 20 seconds, 30 mW output
power and 0.07 cm2 beam area (IBRAMED laserpulse). PCSMC were irradiated one time alone
with laser and analyzed after 24 and 48 hours. Immediately before of irradiation, the cell cul-
ture medium was replaced to phosphate-bufferd saline (PBS) to avoid loss of laser energy
through absorption by colored culture medium [21]. Furthermore, the beam was positioned
perpendicularly at 1 cm of lower surface plate and irradiation was performed by one point at
the center of each culture well, without moving the laser tip. During these procedures the room
was remained without light.
PCSMC Analysis
Morphological characteristics of the PCSMC were investigated and compared by inverted mi-
croscope (Nikon, Eclipse TS100/TS100F) during the experimental period. Primary muscle cells
diameter was quantified by measuring a total of 100 tube diameters from ten random fields at
20× magnification using the ImagePro-Express software (Media Cybernetic, Silver Spring,
MD, USA). All data are expressed as the mean ± SD.
MTT Assay for PCSMC Proliferation
The metabolic activity of cells was assessed by tetrazolium [3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide] (MTT; Sigma) assay. Bioreduction of tetrazolium salts prob-
ably reflects the integrated pyridine nucleotide dependent redox state of the cell. Therefore, the
amount of formazan product is proportional to the metabolic activity of cells in culture and
provides a widely used, although indirect, measurement of cell proliferation [22]. Briefly,
PCSMC were washed in PBS, treated with MTT solution (5 mg/ml, tetrazolium salt) and incu-
bated for 4h at 37°C. After 4 h, the cell supernatants were discarded, MTT crystals were dis-
solved with acid isopropanol and the absorbance measured at 570 nm. Plates were analyzed in
a multi-mode microplate reader model Synergy H1M (Bio Tek Instruments, Washington) at
570 nm with a 655 nm reference wave length to quantify the amount of formazan product,
which reflects the number of cells in culture. Wells that did not contain cells were used as a
zero point of absorbance. All assays were performed in triplicate.
Effects of LLLT onmdxMuscle Cells
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Intracellular calcium content
For qualitative and quantitative measurements of intracellular calcium concentrations, [Ca2+]i,
cells were loaded with calcium-sensitive dye Fluo-4 (Molecular Probes, Oregon, USA). PCSMC
were loaded with the dye Fluo-4 AM for 60 min at room temperature at a concentration of
1 mmol/L (plus 0.005% Pluronic F-127 (Invitrogen, Oregon, USA)), as described previously
[23]. The intensities of fluo-4 fluorescence was monitored on a fluorescent inverted microscope
(Nikon, Eclipse TS100/TS100F), at excitation and emission wavelengths of 494 and
516 nm, respectively.
Determination of H2O2 Production in PCSMC
Skeletal muscle cells were maintained in phenol red-free culture medium and muscle-derived
ROS were determined using a fluorescence assay. The Amplex UltraRed reagent (50 μM) and
HRP (0.1 U/ml) were added for 60 min. Amplex reacts with H2O2, in the presence of HRP, to
produce resorufin, a red fluorescent and stable compound. The fluorescence signal of resorufin
was determined at 530 (excitation) and 590 nm wavelength (emission). Measurements of ROS
were previously calibrated using exogenous 10 μMH2O2 (positive control). All measurements
were performed in phenol red-free culture medium (1 ml), pH 7.4, at 37°C.
Western blotting
Proteins were extracted in a buffer containing Tris–HCl (100 mM), pH 7.5; EDTA (10 mM),
pH 8.0; sodium pyrophosphate (10 mM); sodium fluoride (0.1 mM); sodium orthovanadate
(10 mM); PMSF (2 mM); and aprotinin (10 μg/ml). The cell extracts were sonicated for 30 s at
4°C. The homogenates were centrifuged at 11,000 g for 20 min at 4°C and the supernatants
were treated with Triton X-100 (1%) and transferred to a −80°C freezer until being used for
Western blotting analysis. An aliquot from the supernatant was used to determine the total
protein content by the Bradford method. Thirty μg of total protein homogenate was loaded on
6%–15% SDS-polyacrylamide gels. Proteins were transferred from the gels to a nitrocellulose
membrane using a submersion electrotransfer apparatus (Bio-Rad Laboratories, Hercules, Cal-
ifornia). Membranes were blocked for 2 h at room temperature with 5% skim milk/Tris-HCl
buffer saline-Tween buffer (TBST; 10 mM Tris-HCl, pH 8, 150 mMNaCl, and 0.05% Tween
20). The membranes were incubated with the primary antibodies overnight at 4°C, washed in
TBST, incubated with the peroxidase-conjugated secondary antibodies for 2 h at room temper-
ature, and developed using the SuperSignal West Pico Chemiluminescent Substrate kit (Pierce
Biotechnology, Rockford, Illinois). To control protein loading, Western blot transfer, and non-
specific changes in protein levels, the blots were stripped and reprobed for glyceraldehyde-
3-phosphate dehydrogenase (GAPDH). Band intensities were quantified using ImageJ 1.38X
(National Institutes of Health, Bethesda, Maryland) software. The following primary antibodies
were used for Western blotting: (1) Dystrophin (mouse monoclal, Vector Laboratories, On-
tario, Canadá); (2) NF-κB (goat polyclonal, Santa Cruz Biotechnology, Santa Cruz, California);
(3) TNF-α (rabbit anti-mouse polyclonal, Chemical, USA); (4) 4-HNE (goat polyclonal, Santa
Cruz Biotechnology, Santa Cruz, California); (5) MyoD (rabbit polyclonal, Santa Cruz Biotech-
nology, Santa Cruz, California); (6) Anti-Skeletal Myosin (mouse monoclonal, Sigma; Saint
Louis, USA); (7) glyceraldehyde-3-phosphate dehydrogenase (GAPDH; rabbit polyclonal,
Santa Cruz Biotechnology, Santa Cruz, California). The secondary antibody used was peroxi-
dase-labeled affinity purified mouse, anti-goat or rabbit IgG antibody (KPL).
Effects of LLLT onmdxMuscle Cells
PLOS ONE | DOI:10.1371/journal.pone.0128567 June 17, 2015 4 / 14
Superoxide dismutase activity (SOD)
SOD activity was analyzed by the reduction of nitroblue tetrazolium using a Xanthine–
Xanthine oxidase system, that is, superoxide generation [24]. The results were expressed as
SOD units per mg of protein.
Glutathione (GSH) content
Total GSH content was determined by Ellman's reaction using 5050-dithio-bis-2-nitrobenzoic
acid (DTNB) as described by Anderson [25]. The intensity of the yellow color was read at
412 nm. The results were expressed as nmol per mg of protein.
Glutathione peroxidase activity (GPx)
GPx activity was quantified by following the decrease in absorbance at 365 nm induced by 0.25
mMH2O2 in the presence of reduced glutathione (10 mM), NADPH, (4 mM), and 1 U enzy-
matic activity of GR [26]. Results were expressed as nmol per min per mg of protein.
Glutathione reductase activity (GR)
GR activity was measured according to Carlberg and Mannervick [27], following the decrease
in absorbance at 340 nm induced by oxidized glutathione in the presence of NADPH in phos-
phate buffer, pH 7.8. Absorbance changes were read between 1 and 10 min. Results were ex-
pressed as nmol per min per mg of protein.
Statistical Analysis
All data are expressed as mean ± standard deviation (SD). Statistical analysis for direct compar-
ison between means of groups was performed by ANOVA one way, followed by Bonferroni
test used for multiple statistical comparisons between groups. P0.05 was considered
statistically significant.
Results
Morphology and cell proliferation in control and dystrophic primary
muscle cells
Day 1 shows undifferentiated dystrophin-deficient (mdx) muscle cells; day 3 shows maturation
process inmdxmuscle cells and day 6 shows complete morphological maturation with orga-
nized sarcomeric structures (Fig 1A). PCSMC from normal (C57BL/10) andmdx primary
muscle cells showed a similar time-course development, characterized by typical progression of
proliferation to differentiation and fusion into thick, branching myotubes (Fig 1A). Contractile
fibers were observed at 7 days in both cultures. The presence or absence of dystrophin was veri-
fied using western blots (Fig 1B). The significant difference in cell proliferation, as evaluated by
MTT assay, was observed between the control and themdx untreated cultures (Fig 1C). Like-
wise, themdx LA 24 andmdx LA 48 groups showed significant increase (by 15% for both
groups) in cell proliferation compared tomdx untreated cultures. Morphological quantification
by the diameter of the primary muscle cells from control andmdx groups proved that all cells
were following a growth pattern (Fig 1D). Laser-treated-dystrophic primary muscle cells (mdx
LA 24 group) showed greater diameter (Ctrl: 26 μm;mdx untreated: 26 μm;mdx LA 24: 33 μm;
mdx LA 48: 28 μm) compared to other experimental groups (Fig 1D).
Effects of LLLT onmdxMuscle Cells
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Myogenic regulatory factors and Myosin Heavy Chain in control and
dystrophic primary muscle cells
A number of reports have shown that the use of laser therapy is associated with the promotion
of myogenesis. So, in this study we also evaluated the MyoD levels (Fig 2A) and Myosin Heavy
Chain levels (MyHC) (Fig 2B). The primary muscle cells showed a reduction of MyoD levels
formdx (by 46%),mdx LA 24 (by 58%) andmdx LA 48 (by 80%) groups compared to the con-
trol. Also, it was observed that themdx LA 48 group showed a reduction in the MyoD levels by
34% and 22% in relation to the untreatedmdx andmdx LA 24 groups, respectively. The prima-
ry muscle cells showed a reduction of Myosin Heavy Chain levels formdx (by 48%),mdx LA
24 (by 56%) andmdx LA 48 (by 24%) groups compared to the control. Themdx LA 48 group
showed a increase in the Myosin Heavy Chain levels by 32% and 43% in relation to the untreat-
ed andmdx LA 24 groups, respectively.
Fig 1. Morphology and cell proliferation in control and dystrophicmuscle cells. In (A), morphology of normal (Ctrl) and dystrophic primary muscle
cultures untreated (mdx untreated) and LLLT treatment analyzed after 24 hours (mdx LA 24) and 48 hours (mdx LA 48). Day 1 shows undifferentiated
dystrophin-deficient (mdx) muscle cells; day 3 shows maturation process inmdxmuscle cells and day 6 shows complete morphological maturation with
organized sarcomeric structures. In (B), immunoblot analysis of dystrophin and graph showing protein level in the primary muscle cells from Ctrl,mdx
untreated,mdx LA 24 andmdx LA 48. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. In (C), cell proliferation was
assessed by measurement of MTT assay in the primary muscle cells from Ctrl,mdx untreated,mdx LA 24 andmdx LA 48. In (D), diameter myotubes from
Ctrl,mdx untreated,mdx LA 24 andmdx LA 48. All the experiments were performed in triplicate, and the relative value of the band intensity was quantified
and normalized by the corresponding Ctrl. a P< 0.05 versus Ctrl; b P< 0.05 versusmdx untreated; c P< 0.05 versusmdx LA 24. Error bars, SD.
doi:10.1371/journal.pone.0128567.g001
Effects of LLLT onmdxMuscle Cells
PLOS ONE | DOI:10.1371/journal.pone.0128567 June 17, 2015 6 / 14
Intracellular calcium concentrations in control and dystrophic primary
muscle cells
A significant difference in [Ca2+]i was found by comparing dystrophic-laser and control pri-
mary muscle cells (Fig 3A and 3B). Themdx LA 24 andmdx LA 48 groups showed a significant
increase in [Ca2+]i by 20% and 11%, respectively, compared to the Ctrl group (Fig 3B). In addi-
tion, themdx LA 24 group showed higher [Ca2+]i (13% and 9%, respectively) compared to
mdx untreated andmdx LA 48 groups.
Analysis of oxidative stress in control and dystrophic primary muscle
cells
In order to analyze the laser effects on oxidative stress in dystrophic primary muscle cells, we
determined 4-hydroxynonenal (4-HNE)-protein adduct levels; H2O2 production; glutathione
(GSH) content and superoxide dismutase (SOD); glutathione peroxidase (GPx); and glutathi-
one reductase (GR) activity. Bands of 4-HNE-protein adducts are shown in Fig 4A. Proteins
from 17 to 170 kDa were observed in all groups. The 4-HNE protein adduct levels were signifi-
cantly higher inmdx primary muscle cells (by 19%) compared to control primary muscle cells
(P<0.05; Fig 4A). Reduction of 13% on the 4-HNE protein adduct levels was observed in the
mdx LA 48 group (P<0.05; Fig 4A).Mdx primary muscle cells showed a significant increase in
H2O2 production (by 20%) compared to control primary muscle cells (Fig 4B). Treatment with
laser significantly decreased the H2O2 production (by 17% formdx LA 24 and 30% formdx LA
48) in dystrophic primary muscle cells (Fig 4B). GSH levels were significantly higher inmdx
primary muscle cells (by six times) compared to control primary muscle cells (P<0.05; Fig 4C).
LLLT treatment significantly decreased the GSH levels (by 73% formdx LA 24 and 60% for
mdx LA 48) in dystrophic primary muscle cells (Fig 4C). The effect of the laser treatment on
SOD, GPx and GR activities is shown in Table 1. The increase of SOD, GPx and GR activities
inmdx group were found to be significant when compared to the Ctrl group (P<0.05; Table 1).
LLLT treatment significantly decreased the GR (by 42% formdx LA 24) and SOD activity (by
47% formdx LA 24 and 32% formdx LA 48) in dystrophic primary muscle cells (Table 1).
Fig 2. MyoD and Myosin Heavy Chain analysis in control and dystrophic muscle cells. Immunoblot analysis of MyoD (A) and Myosin Heavy Chain (B)
and graphs showing protein level in the primary muscle cells from normal (Ctrl) and dystrophic primary muscle cells untreated (mdx untreated) and LLLT
treatment analyzed after 24 hours (mdx LA 24) and 48 hours (mdx LA 48). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading
control. All the experiments were performed in triplicate, and the relative value of the band intensity was quantified and normalized by the corresponding Ctrl.
a P< 0.05 versus Ctrl; b P< 0.05 versusmdx untreated; c P< 0.05 versusmdx LA 24. Error bars, SD.
doi:10.1371/journal.pone.0128567.g002
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Fig 3. Intracellular calcium concentrations in control and dystrophicmuscle cells. In (A), intracellular
calcium concentrations, [Ca2+]i, was assessed by measurement of calcium-sensitive dye Fluo-4 (green) in
the primary muscle cells from normal (Ctrl) and dystrophic primary muscle cells cultures untreated (mdx
untreated) and LLLT treatment analyzed after 24 hours (mdx LA 24) and 48 hours (mdx LA 48). In (B), graph
showing fluorescence intensity of [Ca2+]i in the primary muscle cells from Ctrl,mdx untreated,mdx LA 24 and
mdx LA 48. All the experiments were performed in triplicate and data expressed as mean ± SD. a P< 0.05
versus Ctrl; b P< 0.05 versusmdx untreated; c P< 0.05 versusmdx LA 24.
doi:10.1371/journal.pone.0128567.g003
Effects of LLLT onmdxMuscle Cells
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Fig 4. Analysis of oxidative stress in control and dystrophic muscle cells. In (A), immunoblot analysis shows several bands of 4-HNE-protein adducts,
ranging from 17 to 170 kDa. Graphs show protein level in the muscle cells from Ctrl,mdx untreated,mdx LA 24 andmdx LA 48. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was used as a loading control. In (B), quantification of H2O2 production in the muscle cells from normal (Ctrl) and dystrophic
primary muscle cells untreated (mdx untreated) and LLLT treatment analyzed after 24 hours (mdx LA 24) and 48 hours (mdx LA 48). In (C) analysis of
glutathione levels in the muscle cells from normal (Ctrl) and dystrophic culture cells untreated (mdx untreated) and LLLT treatment analyzed after 24 hours
(mdx LA 24) and 48 hours (mdx LA 48). All the experiments were performed in triplicate and data expressed as mean ± SD. The relative value of the band
intensity was quantified and normalized by the corresponding Ctrl. a P< 0.05 versus Ctrl; b P< 0.05 versusmdx untreated; c P< 0.05 versusmdx LA 24.
doi:10.1371/journal.pone.0128567.g004







Ctrl 24.04±1.45 8.4±5.16 15.0±4.62
mdx
untreated
515.42±10.6 a 118.6±29.29 a 249.5±19.81 a
mdx LA 24 271.7±4.03 ab 132.1±14.47 a 144.2±48.20 ab
mdx LA 48 346.98±7.81 abc 144.6±27 .39 a 248.90±49.43 ac
Analysis of superoxide dismutase (SOD), glutathione peroxidase (GPx) and glutathione reductase activity
(GR) in the primary muscle cells from normal (Ctrl) and dystrophic untreated (mdx untreated) and LLLT
treatment analyzed after 24 hours (mdx LA 24) and 48 hours (mdx LA 48). All the experiments were
performed in triplicate and data expressed as mean ± SD.
a P< 0.05 vs Ctrl group.
b P< 0.05 vs mdx untreated group.
c P< 0.05 vs mdx LA 24 group.
doi:10.1371/journal.pone.0128567.t001
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Analysis of inflammation in control and dystrophic primary muscle cells
Inflammatory response of laser therapy was analyzed by the TNF-α and NF-κB levels (Fig 5A
and 5B). Dystrophic primary muscle cells presented high levels of TNF-α and NF-κB (by 15%
and 22%, respectively) compared to the control. Themdx LA 24 andmdx LA 48 primary mus-
cle cells showed a significant reduction (by 8% and 9%, respectively) on TNF-α levels com-
pared to control. In addition, themdx LA 48 group showed a significant decrease on NF-κB
levels (by 25% and 14%, respectively) compared to Ctrl andmdx LA 24 groups.
Discussion
A variety of lasers with different wavelengths and biological effects are widely used to improve
the repair of muscle damage [12]. In this study, we evaluated the effect of AIGaAs laser irradia-
tion on the some physiological pathways that may lead to muscle damage or regeneration ca-
pacity in dystrophic cell culture.
The understanding of LLLT effect in terms of proliferation and myogenic regulatory factors
(MRFs) can provide an important insight regarding muscle regeneration capacity in dystrophic
cells. Our findings showed that the laser therapy promoted muscle cell proliferation in dystro-
phic cells. Also the morphological examination of the dystrophic cells, treated for 24 hours,
demonstrated a 27% increase in the mean myotube diameter compared to themdx untreated
cells. Furthermore, dystrophic cultures showed earlier differentiation compared to the control
cultures, seen as an early decline in MyoD levels and in addition to this, laser therapy accentu-
ated this down-grade. In addition, the reduction of MyoD levels was accompanied by a signifi-
cant increase in MyHC level after LLLT 48, which leads us to suggest that the LLLT treatment
accelerated the differentiation process in dystrophic muscle cells. Similar to our results,
Yablonka-Reuveni and Anderson [28] reported that the satellite cells frommdxmice display
accelerated differentiation in primary cultures, demonstrated by the reduction in the MyoD ex-
pression and by a proportionate increase in myogenic expression. In addition, Nakano and col-
laborators [29] showed that LLLT increased satellite cells and maintained the diameter of rat
Fig 5. Analysis of inflammation in control and dystrophic muscle cells. Immunoblot analysis of TNF-α (A) and NF-κB (B). Graphs show protein level in
the muscle cells from normal (Ctrl) and dystrophic primary muscle cells untreated (mdx untreated) and LLLT treatment analyzed after 24 hours (mdx LA 24)
and 48 hours (mdx LA 48). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. All the experiments were performed in
triplicate, and the relative value of the band intensity was quantified and normalized by the corresponding Ctrl. a P< 0.05 versus Ctrl; b P< 0.05 versusmdx
untreated; c P< 0.05 versusmdx LA 24. Error bars, SD.
doi:10.1371/journal.pone.0128567.g005
Effects of LLLT onmdxMuscle Cells
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myofibrils submitted to muscle atrophy process. Also, studies have shown that laser therapy af-
fects satellite cell proliferation and differentiation in vitro [30, 31].
Deregulation of calcium concentration has been suggested to be an important factor in-
volved in the pathogenesis of DMD [32]. While some investigators have reported elevated Ca2+
levels in DMD andmdx primary muscle cells [32, 33], others have not observed this increase
[34–36]. Our results indicate that [Ca2+]i did not significantly alter in the dystrophin-deficient
muscle cells. However, laser therapy promoted an increase in [Ca2+]i, particularly in themdx
LA 24 group. Researchers have shown that the high [Ca2+]i is one of the first events observed
after laser therapy in several types of cells [37, 38].
Considering that accumulated ROS levels have an important role in the dystrophic muscle
damage [39, 40], we also analyzed the LLLT effects on H2O2 and 4-HNE-protein adduct levels
(a lipid peroxidation biomarker) in dystrophic muscle cells. Our results are not in agreement
with some of those of previous studies. Lubart and collaborators [41] showed that laser thera-
py produces elevated ROS levels. In contrast, our data demonstrated that the LLLT exhibited
antioxidant capacity by reducing the H2O2 and 4-HNE-protein adduct levels in dystrophic
muscle cells. Another study also found that the laser therapy decreased oxidative stress mark-
ers, such as protein carbonyls and malondialdehyde (MDA) in DMD patients [42], which is
consistent with our results. Huang and collaborators [43] also verified that laser therapy re-
duces oxidative stress in in vitro experiments and suggest that the LLLT mechanism interferes
in the ROS concentration as it promotes changes in the mitochondrial membrane potential.
Another possible explanation for the antioxidant properties of LLLT would be the up-regula-
tion of the cellular antioxidant glutathione (GSH). In this study, we analyzed GSH and its as-
sociated regulatory enzymes (glutathione peroxidase- GPx and glutathione reductase-GR). At
the same time, we also evaluated the SOD activity. The data obtained from GSH levels and
GPx, GR and SOD activity suggest that the protective effects of LLLT could not be due to up-
regulation of the antioxidant defense system. We suggest the laser acted directly as a scavenger
of superoxide anions independent the enzymatic antioxidant system. This hypothesis is sup-
ported by work of Lim et al. [44], which showed that LLLT treatment can help remove the in-
tracellular superoxide anion in SOD-inactivated cells, resulting in a decrease in
lipid peroxidation.
Elevated ROS levels may be important in the activation of inflammatory pathways in the
mdxmuscle [45] and LLLT is also widely used to modulate the inflammatory process [46–48].
Our results showed that laser therapy has a pronounced anti-inflammatory effect in dystrophic
muscle cells, by reducing the NF-kB and TNF-α levels. In agreement with our results, an in
vivo study found that LLLT decreased the levels of several inflammatory markers, such as
TNF-α, IL-6 and COX-2 in the dystrophic muscle ofmdxmice [49]. In addition, this work
demonstrates that the inflammatory response reduction was accompanied by a decrease in dys-
trophic muscle damage [49]. Another study also showed the protective effects of LLLT against
muscle damage during postnatal development in hindlimb muscles of dystrophic mice [50].
Although the researchers did not clarify the LLLT mechanisms involved in this result, they sug-
gest it may be associated with anti-inflammatory processes, enhanced angiogenesis and regen-
eration in dystrophic muscle [50].
In conclusion, our results, based on the source and parameters chosen, provide insights into
potential applications of LLLT in promoting cell proliferation and lessening oxidative stress
and inflammation process in dystrophin-deficient muscle cells. Although further studies are
needed in order to clarify the LLLT action mechanisms in dystrophic muscle cells, we suggest
that LLLT could be a helpful alternative therapy to be associated with other treatment
for dystrophinopathies.
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